H.R. 3682 · 117th Congress · House

Improving Transparency to Lower Drug Costs Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Jun 1, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Improving Transparency to Lower Drug Costs Act of 2021

This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.

Action Timeline

6
  1. JUN 02, 2021•Committee

    Referred to the Subcommittee on Health.

  2. JUN 01, 2021•IntroReferral

    Introduced in House

  3. JUN 01, 2021•IntroReferral

    Introduced in House

  4. JUN 01, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. JUN 01, 2021•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. JUN 01, 2021•Committee

    Referred to the Subcommittee on Health.

Committees

4

Health Subcommittee

hsif14

Referred: Jun 2, 2021

Active

Health Subcommittee

hswm02

Referred: Jun 1, 2021

Active

Ways and Means Committee

hswm00

Referred: Jun 1, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jun 1, 2021

Active